SG10201708052XA - Increasing virus-like particle yield in plants - Google Patents

Increasing virus-like particle yield in plants

Info

Publication number
SG10201708052XA
SG10201708052XA SG10201708052XA SG10201708052XA SG10201708052XA SG 10201708052X A SG10201708052X A SG 10201708052XA SG 10201708052X A SG10201708052X A SG 10201708052XA SG 10201708052X A SG10201708052X A SG 10201708052XA SG 10201708052X A SG10201708052X A SG 10201708052XA
Authority
SG
Singapore
Prior art keywords
plants
particle yield
increasing virus
virus
increasing
Prior art date
Application number
SG10201708052XA
Other languages
English (en)
Inventor
Marc-Andre D'aoust
Manon Couture
Louis-Philippe Vezina
Original Assignee
Medicago Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicago Inc filed Critical Medicago Inc
Publication of SG10201708052XA publication Critical patent/SG10201708052XA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1018Orthomyxoviridae, e.g. influenza virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16223Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16211Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
SG10201708052XA 2011-09-30 2012-09-28 Increasing virus-like particle yield in plants SG10201708052XA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161541780P 2011-09-30 2011-09-30

Publications (1)

Publication Number Publication Date
SG10201708052XA true SG10201708052XA (en) 2017-11-29

Family

ID=47994080

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201708052XA SG10201708052XA (en) 2011-09-30 2012-09-28 Increasing virus-like particle yield in plants
SG11201400712VA SG11201400712VA (en) 2011-09-30 2012-09-28 Increasing virus-like particle yield in plants

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201400712VA SG11201400712VA (en) 2011-09-30 2012-09-28 Increasing virus-like particle yield in plants

Country Status (27)

Country Link
US (1) US11155581B2 (cs)
EP (2) EP2760882B1 (cs)
JP (1) JP6248040B2 (cs)
KR (1) KR101974017B1 (cs)
CN (2) CN116218900A (cs)
AU (1) AU2012315421C1 (cs)
BR (1) BR112014007474A2 (cs)
CA (1) CA2850407C (cs)
DK (1) DK2760882T5 (cs)
ES (1) ES2951259T3 (cs)
FI (1) FI2760882T3 (cs)
HR (1) HRP20230695T1 (cs)
HU (1) HUE062759T2 (cs)
IL (1) IL231587B (cs)
IN (1) IN2014CN03077A (cs)
MX (2) MX358883B (cs)
MY (1) MY184072A (cs)
NZ (1) NZ622731A (cs)
PH (1) PH12014500640A1 (cs)
PL (1) PL2760882T3 (cs)
PT (1) PT2760882T (cs)
RU (1) RU2682752C2 (cs)
SG (2) SG10201708052XA (cs)
SI (1) SI2760882T1 (cs)
TW (1) TWI700368B (cs)
WO (1) WO2013044390A1 (cs)
ZA (1) ZA201403059B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
MX358883B (es) 2011-09-30 2018-08-31 Medicago Inc Aumentar el rendimiento de particulas similares a virus en plantas.
ES2803508T3 (es) * 2013-03-28 2021-01-27 Medicago Inc Producción de partículas similares al virus de la gripe en plantas
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
AU2015205805B2 (en) * 2014-01-10 2020-11-12 Aramis Biotechnologies Inc. CPMV enhancer elements
AU2015234595B2 (en) * 2014-03-27 2021-03-25 Medicago Inc. Modified CPMV enhancer elements
EP3765618A4 (en) * 2018-03-14 2022-01-05 Medicago Inc. PLANT EXPRESSION ACTIVATOR
TW202016308A (zh) * 2018-06-27 2020-05-01 加拿大商苜蓿股份有限公司 流感病毒血球凝集素突變體
BR112021017899A2 (pt) * 2019-03-14 2021-12-21 Medicago Inc Intensificador de expressão vegetal endógeno
WO2021236908A2 (en) * 2020-05-20 2021-11-25 Biomarin Pharmaceutical Inc. Use of regulatory proteins for the production of adeno-associated virus

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5428147A (en) 1983-04-15 1995-06-27 Mycogen Plant Science, Inc. Octopine T-DNA promoters
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US5036006A (en) 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US4962028A (en) 1986-07-09 1990-10-09 Dna Plant Technology Corporation Plant promotors
US5232833A (en) 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
US5805417A (en) 1995-10-13 1998-09-08 Hitachi, Ltd. Heat dissipation structure in a portable computer including a heat dissipation block extending from a heat dissipation plate through a first circuit board to a CPU on a second circuit board
AU6512299A (en) 1998-10-07 2000-04-26 Boyce Institute For Plant Research At Cornell University Gemini virus vectors for gene expression in plants
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
RU2164148C1 (ru) * 2000-08-09 2001-03-20 Петров Рэм Викторович Вакцина против вируса гриппа и способ ее получения
ZA200508930B (en) * 2003-05-05 2007-03-28 Thompson Boyce Inst Plant Research Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
CA2524799A1 (en) 2003-05-05 2004-11-18 Dow Agrosciences Llc Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
WO2006119516A2 (en) * 2005-04-29 2006-11-09 University Of Cape Town Expression of viral proteins in plants
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
CA2625406C (en) * 2005-10-18 2016-08-09 Novavax, Inc. Functional influenza virus like particles (vlps)
CA2627105A1 (en) * 2005-10-26 2007-05-03 Protelix, Inc. Influenza combinatorial antigen vaccine
CN101484466A (zh) 2006-02-16 2009-07-15 美国国有健康与人类服务部(马里兰州) 针对流感病毒的抗病毒剂和疫苗
ES2534332T3 (es) 2006-03-07 2015-04-21 Vaxinnate Corporation Composiciones que incluyen hemaglutinina, métodos de preparación y métodos de uso de las mismas
EP1998814A4 (en) 2006-05-11 2010-06-16 Novavax Inc NEW VACCINES AGAINST INFLUENZA M2
EP2029755A1 (en) 2006-05-22 2009-03-04 Plant Bioscience Limited Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants
US8163876B2 (en) * 2006-06-16 2012-04-24 Dow Agrosciences Llc DNA sequences, vectors and proteins of avian influenza hemagglutinin
US8697088B2 (en) 2007-05-25 2014-04-15 Novavax, Inc. VLPs derived from cells that do not express a viral matrix or core protein
CA2795379A1 (en) 2007-06-15 2008-12-18 Centre National De La Recherche Scientifique Modifying glycoprotein production in plants
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
DK2610345T3 (en) * 2007-11-27 2015-12-07 Medicago Inc RECOMBINANT INFLUENZA VIRUS SIMULAR PARTICULARS (VLPS) MADE IN TRANSGENE PLANTS THAT EXPRESS HEMAGGLUTININ
GB0800272D0 (en) 2008-01-08 2008-02-13 Plant Bioscience Ltd Protein expression systems
SG187500A1 (en) 2008-01-21 2013-02-28 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
CN102089432A (zh) 2008-07-08 2011-06-08 麦迪卡格公司 可溶性重组流感抗原
PT2318530T (pt) 2008-07-18 2016-09-30 Medicago Inc Novo epítopo de imunização contra o vírus da gripe
CA2736796A1 (en) 2008-08-27 2010-03-04 Arizona Board Of Regents For And On Behalf Of Arizona State University A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
CA2787099A1 (en) 2009-03-30 2010-10-14 Anice C. Lowen Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
NZ597401A (en) 2009-06-24 2013-09-27 Medicago Inc Chimeric influenza virus-like particles comprising hemagglutinin
FR2947875B1 (fr) 2009-07-10 2011-07-08 Raymond A & Cie Dispositif de fixation a elements de fixation multiples dont l'un est flottant
WO2011011390A1 (en) 2009-07-20 2011-01-27 Novavax, Inc. Purified recombinant influenza virus ha proteins
AU2010300033B2 (en) 2009-09-22 2015-01-22 Aramis Biotechnologies Inc. Method of preparing plant-derived VLPS
JP2013520167A (ja) 2010-02-18 2013-06-06 テクノヴァックス,インコーポレイテッド 万能ウイルス様粒子(vlp)インフルエンザワクチン
EP2624864B1 (en) 2010-10-04 2017-12-06 Massachusetts Institute of Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
TWI526539B (zh) 2010-12-22 2016-03-21 苜蓿股份有限公司 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
PL220281B1 (pl) 2011-09-23 2015-09-30 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Szczepionka DNA, sposób indukowania odpowiedzi immunologicznej, przeciwciała specyficznie rozpoznające białko hemaglutyniny H5 wirusa grypy i zastosowanie szczepionki DNA
US11390878B2 (en) * 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
MX358883B (es) 2011-09-30 2018-08-31 Medicago Inc Aumentar el rendimiento de particulas similares a virus en plantas.
JP6205359B2 (ja) 2012-07-23 2017-09-27 有限会社生物資源研究所 ワクチン
ES2803508T3 (es) 2013-03-28 2021-01-27 Medicago Inc Producción de partículas similares al virus de la gripe en plantas

Also Published As

Publication number Publication date
MX358883B (es) 2018-08-31
SG11201400712VA (en) 2014-04-28
SI2760882T1 (sl) 2023-10-30
FI2760882T3 (fi) 2023-07-17
AU2012315421C1 (en) 2019-12-05
HK1200179A1 (en) 2015-07-31
DK2760882T3 (da) 2023-07-03
IL231587A0 (en) 2014-05-28
ZA201403059B (en) 2019-07-31
EP2760882A1 (en) 2014-08-06
PL2760882T3 (pl) 2023-09-11
IL231587B (en) 2020-06-30
PT2760882T (pt) 2023-08-07
BR112014007474A2 (pt) 2017-04-04
KR101974017B1 (ko) 2019-04-30
CA2850407A1 (en) 2013-04-04
MX2014003776A (es) 2014-08-21
CN116218900A (zh) 2023-06-06
AU2012315421A1 (en) 2014-04-10
HUE062759T2 (hu) 2023-12-28
US20150104480A1 (en) 2015-04-16
CA2850407C (en) 2021-11-23
TW201329235A (zh) 2013-07-16
JP2014530006A (ja) 2014-11-17
EP3626733B1 (en) 2024-01-24
RU2682752C2 (ru) 2019-03-21
JP6248040B2 (ja) 2017-12-13
HRP20230695T1 (hr) 2023-12-22
EP2760882B1 (en) 2023-05-24
EP3626733A1 (en) 2020-03-25
US11155581B2 (en) 2021-10-26
TWI700368B (zh) 2020-08-01
RU2014116371A (ru) 2015-11-10
IN2014CN03077A (cs) 2015-07-03
PH12014500640A1 (en) 2014-05-05
NZ622731A (en) 2016-04-29
WO2013044390A1 (en) 2013-04-04
CN103930435A (zh) 2014-07-16
DK2760882T5 (da) 2024-06-24
MX2018006627A (es) 2020-11-12
MY184072A (en) 2021-03-17
AU2012315421B2 (en) 2017-10-19
ES2951259T3 (es) 2023-10-19
EP2760882A4 (en) 2015-06-10
KR20140068260A (ko) 2014-06-05

Similar Documents

Publication Publication Date Title
IL251338A0 (en) Production of virus-like particles in plants
ZA201403059B (en) Increasing virus-like particle yield in plants
GB2492660B (en) Particle separator
ZA201309220B (en) Micelle-coated crystalline particles
EP2718428A4 (en) PREPARATION RABIESVIRUS-SIMILAR PARTICLE IN PLANTS
EP2698206A4 (en) CONCEALED CRUSHER
EP2695857A4 (en) MODIFIED NATURAL GRAPHITE PARTICLES
IL235290A0 (en) Production of rotavirus-like particles in plants
AP3526A (en) Methods and compositions for increased plant yield
ZA201400154B (en) Solar plant
EP2699670A4 (en) PARTICLES SYNTHETIZED FROM CELLS
EP2698205A4 (en) CONICAL SHREDDER
EP2707480A4 (en) PSEUDOVIRAL PARTICLES (VLPs) AND PREPARATION METHOD THEREOF
GB201202258D0 (en) Methods of controlling seed size in plants
IL229106A (en) Particulate particle
PL2584028T3 (pl) Cząstka
GB2504442B (en) A particle collector apparatus
ZA201502264B (en) Picornavirus-like particle production in plants
GB201100166D0 (en) Collector
GB201119137D0 (en) Energy harvester modelling
AU2011182V (en) SUPA371 Argyranthemum frutescens
GB201220166D0 (en) Power plant